Dihydrosamidin

CAS No. 6005-18-1

Dihydrosamidin( —— )

Catalog No. M24598 CAS No. 6005-18-1

Dihydrosamidin is a natural product. It inhibiting effect on triacylglycerol accumulation in 3T3-L1 preadipocytes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 412 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dihydrosamidin
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydrosamidin is a natural product. It inhibiting effect on triacylglycerol accumulation in 3T3-L1 preadipocytes.
  • Description
    Dihydrosamidin is a natural product. It inhibiting effect on triacylglycerol accumulation in 3T3-L1 preadipocytes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6005-18-1
  • Formula Weight
    388.41
  • Molecular Formula
    C21H24O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)CC(O[C@H]([C@@H]1OC(C)=O)C(C)(C)Oc(cc2)c1c(O1)c2C=CC1=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • pTH-Related Protein ...

    pTH-Related Protein (1-34) (human, mouse, rat), a fragment of parathyroid hormone-related protein, is an anabolic agent. pTH-Related Protein (1-34) (human, mouse, rat) can be used for postmenopausal osteoporosis study.

  • 5-(2-Furyl)-2-hydrox...

    5-(2-Furyl)-2-hydroxybenzoic acid is an inhibitor of glycolate oxidase (GO) and can be used to study metabolism-related disorders such as primary hyperoxaluria type 1 (PH1).

  • Antiproliferative ag...

    Antiproliferative agent-15 is a reagent with anticancer activity. Antiproliferative agent-15 showed antiproliferative activity against human colon cancer (HCT116 and HCT15) and brain cancer (LN-229 and GBM-10).